TERT activates stem cells, depleting BrdU label from LRCs. a, Immunofluorescence for BrdU (red) and CD34 (green) shows maintenance of LRCs in Non-Tg group, but dramatic loss of label in i-TERT mice after doxy treatment (pre-doxy = day 55, post-doxy= day 90). b, Quantification of LRC data from (a), showing number of BrdU+ cells/CD34+ cells. i-TERT (black bars, n=4 mice), Non-Tg (gray bars, n=3 mice), - indicates pre-doxy, + indicates post-doxy. c, LRC analysis from whole mounts of epidermis from tail of mice labeled with BrdU at day 10, switched to doxy at day 40 and analyzed at day 65. (BrdU=red, K14=green). d, Immunofluorescence using Ki-67 (red) to mark proliferating cells and K14 (green) to identify basal layer of skin. e, Quantitation of proliferation index in (d) as Ki-67+ cells/100μm length of basal layer. n=2 mice for each comparison. f, GFP epifluorescence costained with CD34 (inset, confocal microscopy) in skin section from an actin-GFP mouse. g, RNA in situ analysis for TERT mRNA in i-TERT(+doxy) mouse skin. (inset) TERT mRNA expression (cytoplasmic) overlaps in bulge with LRCs, marked by BrdU (nuclear). h, H&E sections from K5tTA+; tetop-TERT+ (−doxy) (bottom) and Non-Tg (top) mice, 20X. Error bars indicate standard deviation. p values based on t-test. *=autofluorescence of hair.